Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1671-1680 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|May 26, 2020
Enabling speed to clinic for monoclonal antibody programs using a pool of clones for IND-enabling toxicity studiesParimala Bolisetty, Gabi Tremml, Sen Xu, et al.
Mabs|August 30, 2021
A non-clinical comparative study of IL-23 antibodies in psoriasisLi Zhou, Yibing Wang, Qi Wan, et al.
Mabs|February 16, 2023
Deciphering cross-species reactivity of LAMP-1 antibodies using deep mutational epitope mapping and AlphaFoldTiphanie Pruvost, Magali Mathieu, Steven Dubois, et al.
Mabs|February 23, 2023
Assessing developability early in the discovery process for novel biologicsMonica L Fernández-Quintero, Anne Ljungars, Franz Waibl, et al.
Mabs|November 17, 2022
Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic miceJerome Egli, Stefan Heiler, Felix Weber, et al.
Mabs|November 25, 2025
Balancing brain exposure, pharmacokinetics and safety of transferrin receptor antibodies for delivery of neuro-therapeuticsBenjamin A Smith, Caitlin B Meeks, Isabel Murray-Brown, et al.
Mabs|November 24, 2025
AbAgym: a well-curated dataset for the mutational analysis of antibody-antigen complexesGabriel Cia, Dong Li, Simón Poblete, et al.
Mabs|November 14, 2025
Advanced cytokine-based immunotherapies: targeted cis-delivery strategies for enhanced anti-tumor efficacy and reduced toxicityLaurène Pousse, Amrita Manchala, Christian Klein, et al.
Mabs|November 7, 2025
Paratope plasticity determines anti-HER2 (4B5) antibody specificityP Daniel Warren, Terry H Landowski, Mark S Dodson, et al.
Mabs|January 7, 2026
Multidimensional maturation of antibody variable domains with machine-learning assistanceTomoyuki Ito, Sakiya Kawada, Hikaru Nakazawa, et al.
Pageof 178

Showing results (1671-1680 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|May 26, 2020
Enabling speed to clinic for monoclonal antibody programs using a pool of clones for IND-enabling toxicity studiesParimala Bolisetty, Gabi Tremml, Sen Xu, et al.
Mabs|August 30, 2021
A non-clinical comparative study of IL-23 antibodies in psoriasisLi Zhou, Yibing Wang, Qi Wan, et al.
Mabs|February 16, 2023
Deciphering cross-species reactivity of LAMP-1 antibodies using deep mutational epitope mapping and AlphaFoldTiphanie Pruvost, Magali Mathieu, Steven Dubois, et al.
Mabs|February 23, 2023
Assessing developability early in the discovery process for novel biologicsMonica L Fernández-Quintero, Anne Ljungars, Franz Waibl, et al.
Mabs|November 17, 2022
Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic miceJerome Egli, Stefan Heiler, Felix Weber, et al.
Mabs|November 25, 2025
Balancing brain exposure, pharmacokinetics and safety of transferrin receptor antibodies for delivery of neuro-therapeuticsBenjamin A Smith, Caitlin B Meeks, Isabel Murray-Brown, et al.
Mabs|November 24, 2025
AbAgym: a well-curated dataset for the mutational analysis of antibody-antigen complexesGabriel Cia, Dong Li, Simón Poblete, et al.
Mabs|November 14, 2025
Advanced cytokine-based immunotherapies: targeted cis-delivery strategies for enhanced anti-tumor efficacy and reduced toxicityLaurène Pousse, Amrita Manchala, Christian Klein, et al.
Mabs|November 7, 2025
Paratope plasticity determines anti-HER2 (4B5) antibody specificityP Daniel Warren, Terry H Landowski, Mark S Dodson, et al.
Mabs|January 7, 2026
Multidimensional maturation of antibody variable domains with machine-learning assistanceTomoyuki Ito, Sakiya Kawada, Hikaru Nakazawa, et al.
Pageof 178